
Episode #201
Validation of the HAQ Disability Index in immune checkpoint inhibitor-induced inflammatory arthritis
In this Arthritis At Home, we are sharing this year’s #CRArthritis with Dr. Kayla Chubbs, a resident in the rheumatology program at Dalhousie University. She defines what immune checkpoint inhibitor is and how it is used as a therapy to treat multiple types of cancer. While treating the cancer, they can put your immune system into overdrive and as a result, cause inflammatory arthritis or worsen an already existing inflammatory arthritis. Dr. Chubbs’ study looks at whether health care providers should use the Health Assessment Questionnaire Disability Index to measure function in this group of patients. In this group of patients, it is challenging to balance the number of immune-suppressive medication as it can negatively impact cancer treatment so instead of treating to remission, health care providers usually treat to improve function. Additional learning resources The Canadian Research Group of Rheumatology in Immuno-Oncology Validation of the Health Assessment Questionnaire Disability Index in immune checkpoint inhibitor-induced inflammatory arthritis Immune checkpoint inhibitor-induced inflammatory arthritis

